Skip to main content
. 2021 Sep 25;29(11):1314–1322. doi: 10.1016/j.jsps.2021.09.012

Table 1.

Baseline evaluation.

Parameter DHA group (n = 30) Control group (n = 30) p-value
Gender; n (%)
Male 11(36.7) 10(33.3) 0.787**
Female 19(63.3) 20(66.7)
Gestational age (days); mean ± SD 31.37 ± 1.5 31.40 ± 1.61 0.934*
Age of admission (days); mean ± SD 1.06 ± 0.36 1.27 ± 0.5 0.07*
Anthropometric measures
Baseline weight (g); mean ± SD 1306.33 ± 152.94 1346.67 ± 123.13 0.265*
Baseline length (cm); mean ± SD 40.33 ± 1.97 39.27 ± 1.26 0.016*
Baseline OFC (cm); mean ± SD 28.30 ± 2 28.07 ± 0.98 0.570*
Natal history
Mode of delivery; n (%)
LSCS 18(60) 20(66.7) 0.592**
VD 12(40) 10(33.3)
Maternal risk factors; n (%)
Absent 11(36.7) 8(26.7) 0.405**
Present 19(63.3) 22(73.3)
Need for resuscitation; n (%)
No 9(30) 10(33.3) 0.781**
Yes 21(70) 20(66.7)

cm, centimeters; DHA, Docosahexaenoic acid; g, grams; LSCS, Lower segment caesarian section; OFC, Occipitofrontal circumference; SD, standard deviation; VD, Vaginal delivery.

*

Student t test; **Chi-Square Test.